Apoptosis-resistant T cells have a deficiency in NF-χB-mediated induction of Fas ligand transcription

European Journal of Immunology

Volumn 29, Issue 3, 1999, Pages 745-754

  Teixeiro, Emma ^a,b   García Sahuquillo, Almudena ^a   Alarcón, Balbino ^c   Bragado, Rafael ^a,d  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d Clínica Nuestra Señora de la Concepción   (Spain)

Author keywords

Apoptosis; Fas ligand; NF B; T cell activation; TCR

Indexed keywords

CD4 ANTIGEN; CYTOKINE; FAS LIGAND; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

APOPTOSIS; ARTICLE; CONSENSUS SEQUENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOGENETICS; LEUKEMIA CELL LINE; PRIORITY JOURNAL; REPORTER GENE; T LYMPHOCYTE; TRANSCRIPTION INITIATION;

EID: 0344938352     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199903)29:03<745::AID-IMMU745>3.0.CO;2-0     Document Type: Article

References (41)

1. Sloan-Lancaster, J. and Allen, P., Altered peptide ligand-induced partial T cell activation: Molecular mechanisms and roles in T cell biology. Annu. Rev. Immunol. 1996. 14: 1-27.
2. Cohen, J. J., Apoptosis. Immunol. Today 1993. 14: 126-130.
3. Ashwell, J. D. and Snow, E. C. (Eds.) Handbook of B and T Lymphocytes. Academic Press, San Diego 1994, pp 63-89.
4. Dhein, J., Walczak, H., Bäumler, C., Debatin, K. M. and Krammer, P. H., Autocrine T cell suicide mediated by APO-1 (Fas/CD95). Nature 1995. 373: 438-441.
5. Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mabhoubl, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F. and Green, D. R., Cell-autonomous Fas (CD95)/Fas-Ligand interaction mediates activation induced apoptosis in T-cell hybridomas. Nature 1995. 373: 441-444.
6. Ju, S. T., Panka, D. J., Cui, H., Ettinger, R., El-Khatib, M., Sherr, D. H., Stanger, B. Z. and Marshak-Rothstein, A., Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995. 373: 444-448.
7. + T cells responding to a bacterial superantigen. J. Immunol. 1995. 154: 4302-4308.
8. Peter, M. E., Dhein, J., Ehret, A., Hellbardt, S., Walczak, H., Moldenhauer, G. and Krammer, P. H., APO-1 (CD95)-dependent and -independent antigen receptor-induced apoptosis in human T and B cell lines. Int. Immunol. 1995. 7: 1873-1877.
9. Zheng, L., Fisher, G., Miller, R. E., Peshon, J., Lynch, D. N. and Lenardo, M. J., Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 1995. 377: 348-351.
10. Anel, A., Buferne, M., Boyer, C., Schmitt-Verhulst, A. and Goldstein, P., T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur. J. Immunol. 1994. 24: 2469-2476.
11. Latinis, K., Carr, L. L., Peterson, E. J., Norian, L. A., Eliason, S. L. and Koretzky, G. A., Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J. Immunol. 1997. 158: 4602-4611.
12. Latinis, K., Norian, L. A., Eliason, S. L. and Koretzky, G. A., Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J. Biol. Chem. 1998. 272: 31427-31434.
13. Holtz-Heppelmann, C. J., Algeciras, A., Badley, A. D. and Paya, C. V., Transcriptional regulation of the human FasL promoter-enhancer region. J. Biol. Chem. 1998. 273: 4416-4423.
14. Hodge, M. R., Ranger, A. M., de la Brouse, F. C., Hoey, T., Grusby, M. J. and Glimcher, L. H., Hyperproliferation and dysregulation of IL-4 expression in NFATp-deficient mice. Immunity 1996. 4: 397-405.
15. Eishen, C. M., Williams, B. L., Zhang, W., Samelson, L. E., Lynch, D. H., Abraham, R. T. and Leibson, P. J., ZAP-70 tyrosine kinase is required for the up-regulation of Fas ligand in activation-induced T cell apoptosis. J. Immunol. 1997. 159: 1135-1139.
16. Qian, D., Mollenauer, M. N. and Weiss, A., Dominant-negative zeta-associated protein 70 inhibits T cell antigen receptor signaling. J. Exp. Med. 1996. 188: 611-618.
17. Mittelstadt, P. R. and Ashwell, J. D., Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression. Mol. Cell. Biol. 1998. 18: 3744-3751.
18. Li-Weber, M., Laur, O., Hekele, A., Coy, J., Walczak, H. and Krammer, P. H., A regulatory element in the CD95(APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation. Eur. J. Immunol. 1998. 28: 2373-2383.
19. Norian, L. A., Latinis, K. M. and Koretzky, G. A., A newly identified response element in the CD95 ligand promoter contributes to optimal inducibility in activated T cells. J. Immunol. 1998. 161: 1078-1082.
20. Kuo, C. T., Veselite, M. L. and Leiden, J. M., LKLF: A transcriptional regulator of single-positive T cell quiescence and survival. Science 1997. 277: 1986-1990.
21. Matsui, K., Omura, S., Cui, H., Schauer, S. L., Sonenshein, G. E. and Ju, S., Proteasome regulation of Fas ligand cytotoxicity. Eur. J. Immunol. 1998. 27: 2269-2278.
22. Ivanov, V. N., Lee, R. K., Podack, E. R. and Malek, T. R., Regulation of Fas-dependent activation-induced T cell apoptosis by cAMP signaling: a potential role for transcription factor NF-(greek small letter script kappa)B. Oncogene 1997. 14: 2455-2464.
23. Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Manboubi, A. and Green, D. R., DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-(greek small letter script kappa)B and AP-1. Mol. Cell 1998. 1: 543-551.
24. Rodriguez-Tarduchy, G., García-Sahuquillo, A., Alarcón, B. and Bragado, R., Apoptosis but not other activation events is inhibited by a mutation in the transmembrane domain of T cell receptor β that impairs CD3ζ association. J. Biol. Chem. 1996. 271: 30417-30425.
25. García-Sahuquillo, A., Roumier, A., Teixeiro, E., Bragado, R. and Alarcón, B., T cell receptor (TCR) engagement in apoptosis-defective, but interleukin 2 (IL-2)-producing, T cells results in impaired ZAP70/CD3ζ association. J. Exp. Med. 1998. 187: 1179-1192.
26. Takahashi, T., Tanaka, M., Inazawa, J., Abe, T., Suda, T. and Nagata, S., Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 1994. 6: 1567-1574.
27. Chatuverdi, M. M., Kumar, A., Darnay, B. G., Chainy, G. B., Agarwal, S. and Aggarwal, B. B., Sanguinarine (Pseudochelerythrine) is a potent inhibitor of NF-kB activation, IkBα phosphorylation, and degradation. J. Biol. Chem. 1997. 272: 30129-30134.
28. McCaffrey, P. G., Perrino, B. A., Soderling, R. R. and Rao, A., NF-ATp, a T lymphocyte DNA-binding protein that is target for calcineurin and immunosuppressive drugs. J. Biol. Chem. 1993. 268: 3747-3752.
29. Mattila, P. S., Ullman, K. S., Fiering, S., Emmel, E. A., McCutcheon, M., Crabtree, G. R. and Herzenberg, L. A., The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. EMBO J. 1990. 9: 4425-4433.
30. Schmidt, A., Hennighaussen, L. and Siebenlist, U., Inducible nuclear factor binding to the (greek small letter script kappa)B elements of the human immunodeficiency virus enhancer in T cells can be blocked by cyclosporin A in a signal-dependent manner. J. Virol. 1990. 64: 4037-4041.
31. Frantz, B., Nordby, E. C., Bren, G., Steffan, N., Paya, C. V., Lincaid, R. L., Tocci, M. J., O'Keefe, S. J. and O'Neill, E. A., Calcineurin acts in synergy with PMA to inactivate IkB/MAD3, an inhibitor of NF-kB. EMBO J. 1994. 13: 861-870.
32. 2+ dependent signal transduction. J. Immunol. 1995. 155: 4685-4691.
33. O'Keefe, S. J., Tamura, R. I., Rincaid, M. J., Tocci, M. J. and Neil, E. A., FK-506 and Cs-A-sensitive activation of the IL-2 promoter by calcineurin. Nature 1992. 357: 692-695.
34. + cytotoxic T lymphocyte clones. Eur. J. Immunol. 1995. 25: 3381-3387.
35. McCaffrey, P. J., Jain, J., Jamieson, C., Sen, R. and Rao, A., A T cell nuclear factor resembling NF-AT binds to an NF-(greek small letter script kappa)B site and to the conserved lymphokine promoter sequence "cytokine-1". J. Biol. Chem. 1992. 267: 1864-1871.
36. Casolaro, V., Georas, S. N., Song, Z., Zubkoff, I. D., Abdulkadir, S. A., Thanos, D. and Ono, S. J., Inhibition of NF-AT-dependent transcription by NF-(greek small letter script kappa)B: Implications for differential gene expression in T helper cell subsets. Proc. Natl. Acad. Sci. USA 1995. 92: 11623-11627.
37. Oyaizu, N. S., Than, S., McCloskey, T. W. and Pahwa, S., Requirement of p56lck in TCR/CD3-mediated apoptosis and Fas-ligand induction in Jurkat cells. Biochem. Biophys. Res. Commun. 1995. 213: 994-998.
38. Lederer, J. A., Liou, J. S., Kim, S., Rice, N. and Lichtman, A. H., Regulation of NF-(greek small letter script kappa)B activation in T helper 1 and T helper 2 cells. J. Immunol. 1996. 156: 56-63.
39. 2+ influx. Functional sinergy between Raf and Calcineurin. J. Immunol. 1996. 157: 5277-5283.
40. Rodriguez, M. S., Wright, J., Thompson, J., Thomas, D., Baleux, F., Virelizier, J.-L., Hay, R. T. and Arenzana-Seisdedos, F., Identification of lysine residues required for signal-induced ubiquitination and degradation of I(greek small letter script kappa)Bα in vivo. Oncogene 1996. 12: 2425-2435.
41. Arenzana-Seisdedos, F., Fernández, B., Dominguez, I., Jacque, J. M., Thomas, D., Díaz-Meco, M. T., Moscat, J. and Virelizier, J.-L., Phosphatidylcoline hydrolysis activates NF-(greek small letter script kappa)B and increases human immunodeficiency virus replication in human monocytes and T lymphocytes. J. Virol. 1993. 67: 6596-6604.